"Problematic" patent settlements on the decline, says EC
This article was originally published in Scrip
Executive Summary
The European Commission's inquiry into competition in the pharmaceutical sector appears to have borne fruit, at least as far as the number of questionable patent settlements between originator and generics companies is concerned.